Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), tirzepatide (Mounjaro, Zepbound), and dulaglutide (Trulicity) can slow down gastric emptying
According to experts, GLP-1 agonist drugs also help decrease the overall mortality rate in people with type 2 diabetes
Its modified amino acid sequence provides enhanced stability and an extended biological half-life compared to native IGF-1, making it a valuable research compound for studies involving growth factor signaling, cellular proliferation, tissue regeneration, and metabolic pathways
Upon binding, this receptor activation may trigger a series of intracellular events that potentially culminate in the release of stored growth hormone from somatotroph cells (GH-producing cells) in the anterior pituitary
By supporting each others functions, they can contribute to better energy levels, improved detoxification, and enhanced cellular health